* Health Catalyst Inc HCAT.OQ reported a quarterly
adjusted loss
of 13 cents per share for the quarter ended in September. The
mean expectation of fourteen analysts for the quarter was for a
loss of 19 cents per share.
* Revenue rose 10.7% to $68.35 million from a year ago;
analysts
expected $66.79 million.
* Health Catalyst Inc's reported EPS for the quarter was a
loss
of 84 cents.
* The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Health Catalyst Inc shares had fallen by 29.2% this
quarter and
lost 82.7% so far this year.
* The company reported a quarterly loss of $45.74 million.
* Wall Street's median 12-month price target for Health
Catalyst
Inc is $17.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 10:52 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.19 -0.13 Beat
Jun. 30 2022 -0.10 -0.03 Beat
Mar. 31 2022 -0.11 -0.06 Beat
Dec. 31 2021 -0.21 -0.19 Beat